Theravance Biopharma Inc (TBPH)
Total Liabilities
$180.07M
Quarterly · Period ending: · USD
TBPH Total Liabilities
Latest reported$180.07Mperiod ending
Latest reported$180.07Mperiod ending
TBPH Quarterly Total Liabilities ($22.67M → $180.07M)
Quarterly total liabilities
High-resolution chart · PNG
TBPH total liabilities history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Total Liabilities (USD) |
|---|---|
| 180,065,000 | |
| 181,719,000 | |
| 188,847,000 | |
| 182,779,000 | |
| 201,187,000 | |
| 177,599,000 | |
| 178,616,000 | |
| 170,451,000 | |
| 168,340,000 | |
| 166,439,000 | |
| 169,004,000 | |
| 167,460,000 | |
| 166,469,000 | |
| 167,991,000 | |
| 165,600,000 | |
| 282,918,000 | |
| 710,570,000 | |
| 706,809,000 | |
| 713,392,000 | |
| 726,701,000 | |
| 729,625,000 | |
| 748,326,000 | |
| 772,808,000 | |
| 773,724,000 | |
| 766,666,000 | |
| 763,345,000 | |
| 632,666,000 | |
| 628,142,000 | |
| 629,671,000 | |
| 644,517,000 | |
| 611,824,000 | |
| 384,409,000 | |
| 386,977,000 | |
| 416,701,000 | |
| 326,222,000 | |
| 302,042,000 | |
| 302,759,000 | |
| 294,093,000 | |
| 289,023,000 | |
| 58,416,000 | |
| 52,904,000 | |
| 54,588,000 | |
| 57,051,000 | |
| 34,961,000 | |
| 31,805,000 | |
| 35,786,000 | |
| 47,984,000 | |
| 41,884,000 | |
| 45,829,000 | |
| 44,083,000 | |
| 42,212,000 | |
| 32,728,000 | |
| 28,889,000 | |
| 22,754,000 | |
| 22,672,000 |